FROM CODE TO CURE Trademark

Trademark Overview


On Thursday, December 29, 2016, a trademark application was filed for FROM CODE TO CURE with the United States Patent and Trademark Office. The USPTO has given the FROM CODE TO CURE trademark a serial number of 87284571. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 19, 2023. This trademark is owned by Compugen Ltd.. The FROM CODE TO CURE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA
from code to cure

General Information


Serial Number87284571
Word MarkFROM CODE TO CURE
Filing DateThursday, December 29, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 19, 2023
Registration Number5383752
Registration DateTuesday, January 23, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements


Goods and ServicesDrug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code042
First Use Anywhere DateMonday, October 31, 2016
First Use In Commerce DateMonday, October 31, 2016

Trademark Owner History


Party NameCompugen Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHolon 5885849
IL

Party NameCompugen Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHolon 5885849
IL

Party NameCompugen Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHolon 5885849
IL

Trademark Events


Event DateEvent Description
Wednesday, July 19, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, July 19, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 18, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 23, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, October 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 30, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 25, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, September 19, 2017NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, September 18, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 18, 2017LETTER OF SUSPENSION E-MAILED
Monday, September 18, 2017SUSPENSION LETTER WRITTEN
Monday, September 18, 2017USE AMENDMENT ACCEPTED
Tuesday, September 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 10, 2017ASSIGNED TO LIE
Wednesday, August 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 31, 2017AMENDMENT TO USE PROCESSING COMPLETE
Thursday, August 31, 2017USE AMENDMENT FILED
Wednesday, August 30, 2017TEAS AMENDMENT OF USE RECEIVED
Sunday, April 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, April 2, 2017NON-FINAL ACTION E-MAILED
Sunday, April 2, 2017NON-FINAL ACTION WRITTEN
Sunday, March 26, 2017ASSIGNED TO EXAMINER
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 2, 2017NEW APPLICATION ENTERED